Pharma Services Company Valuation: What Are CROs and CDMOs Worth?
A buyer-focused guide to pharma services company valuation covering normalized EBITDA, CRO and CDMO business-model differences, backlog, sponsor quality, capacity, capex, valuation methods, deal structure, and seller proceeds.